human herpes virus 6.spin1

Upload: henrywronger

Post on 05-Apr-2018

227 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/31/2019 Human Herpes Virus 6.Spin1

    1/4

    Chronic Lyme Disease Viral Co-infection

    Human Herpes Virus 6 (HHV-6): Fatigue

    Its Link to Chronic Fatigue Syndrome, Fibromyalgia, Fatigue, andCancer

    Human herpesvirus 6 (HHV-6) was first reported in 1986 and has since become one of the most

    widespread members of human herpes viruses. It is composed of two closely related variants that share

    over 90% of their DNA homology: HHV-6A and HHV-6B.

    Although these two variants are closely related, there are still differences in their epidemiology and

    pathogenicity. HHV-6B is acquired in early childhood, infecting up to 90% of most populations during

    infancy. HHV-6A, on the other hand, is generally not seen until adulthood. The virus is usually found in

    saliva and is presumably spread this way as well.

    HHV-6 is of greatest concern to those patients who are immunocompromised, in particular, those who

    have undergone organ or bone marrow transplants or who are HIV positive and chronic Lyme disease.

    People are carriers of this virus from a young age, and is commonly picked up in dare care centers.

  • 7/31/2019 Human Herpes Virus 6.Spin1

    2/4

    How Does HHV-6 Work?

    The virus attacks certain cells, including CD4 lymphocytes, natural killer cells, oligodendrocytes, CD8

    cells, and microglial cells. HHV-6 is also animmune suppressive virus that also serves to activate other

    viruses. It can be latent in cells for long stretches of time, only to bring about infection later on when

    reactivated. HHV-6 can persist in salivary glands, the kidneys, and even the brain until activated.

    CFS, Fibromyalgia and Autoimmune

    Disease Symptoms Linked to HHV-6.

    HHV-6 infection has been associated with a range of maladies including Chronic Fatigue Syndrome(CFS.)

    Chronic Fatigue patients typically suffer from immunologic abnormalities and neurologic problems. In

    one such study, 30% of CFS patients tested positive in an initial screening for HHV-6. Follow-up cultures

    in patients who initially tested negative, later proved positive in an additional 20%-40% of cases. Healthy

    control patients have not demonstrated positive cultures as described above. The association between

    HHV-6 and CFS reaffirms the link between infection and chronic disease.

    One study suggests that a "smoldering" central nervous system (CNS) infection may play a role in

    conditions that plague millions of Americans. Jikei University Medical School in Tokyo identified a novel

    human herpesvirus-6 (HHV-6) protein, present in Chronic Fatigue Syndrome (CFS) that is a likely

    contributor to the psychological symptoms that are so often associated with the disorder. It was also

    found that 71 percent of Chronic Fatigue Symptom patients had antibody SITH-1. What is so remarkable

    about this discovery is that 53 percent of depression and 76 percent of bipolar disorder sufferers have

    the SITH-1 antibody.

    HHV-6 is one of the infections found invirtually all Chronic Lyme Disease patients a chief contributor to

    fatigue and other neurological symptoms. Antibiotics do not affect this or other herpetic viruses.

    HHV-6 as a Potential Causative toChronic Lyme Disease, Parkinsons, and

    Alzheimers

    http://www.envita.com/chronic-fatigue-syndrome/http://www.envita.com/chronic-fatigue-syndrome/http://www.envita.com/chronic-fatigue-syndrome/
  • 7/31/2019 Human Herpes Virus 6.Spin1

    3/4

    Viruses have been implicated in the development of neurodegenerative diseases such as Alzheimer's,

    Parkinsons, and Multiple Sclerosis (MS.) More specifically, neurotropic virus HHV-6 has been clinically

    shown to be directly linked to many neurologic problems including encephalitis, mesial temporal lobe

    epilepsy, and many others.

    Despite the copious research, HHV-6s route into the central nervous system remains inconclusive.However, among various brain regions examined, the highest frequency of HHV-6 DNA was routinely

    identified in the olfactory bulb/tract region. While further tests must be conducted the olfactory

    pathway does seem likely as at least one pathway for HHV-6 to move into the CNS.

    HHV-6 Infection: Its Role in One Childs

    Acute Lymphoblastic Leukemia

    In one case, a child was found to be infected by HHV-6 and just two months later began an acutelymphoblastic leukemia. This is just another example of the suggestion that viral infections could play a

    major causative role in some childhood leukemia.

    HHV-6 Attacks p53 giving rise to cancers

    The protein p53 is vital for multicellular organisms as it serves to regulate the cell cycle. As a result it is

    an important tumor suppressor that helps the body naturally prevent cancer. The p53 is so critically

    important because of the incessant exposure our cells face on a daily basis. From toxic chemicals,

    viruses, radiation, to an almost endless barrage of others, our cells are continually at risk. And as our

    cells go, we go.

    If cells are damaged in sensitive areas by these marauders, there can be devastating repercussions. It is

    not uncommon to see key regulatory elements damaged and normal cell growth blocked setting the

    stage for irregular growth and a rapid tumor producing result. The tumor suppressor p53 acts as one of

    our best defenses in such circumstance as it snaps into action when it detects DNA damage. The

    typically low levels of the protein rise and initiate protective measures by binding to sites in the genome

    and halts cell division until the damage can be repaired. If it has progressed too far, p53 will initiate

    HHV-6Viral Co-infection of Chronic Lyme

    Disease: Immunity and Cancer

    Implications

    While data is difficult to sort out, the more research that is done seems to further support that

    additional regulatory influences in cell proliferation and cell death, including cytokines and growth

  • 7/31/2019 Human Herpes Virus 6.Spin1

    4/4

    factors, are definitively altered after viral infections. HHV-6 is often the culprit for such significant and

    impactful changes.

    Envitas Fully Engages Chronic Lyme

    Disease Complex and Its DangerousHHV-6Co-infection

    Envita clinical experience in testing chronic Lyme diseasepatients, Chronic fatigue syndrome and

    fibromyalgia shows many have activated forms of co-infection viruses such as HHV-6. That means that

    many Lyme sufferers are likely carriers of this infection as well as others. Biofilm communities and

    immunodeficiencies could contribute toHHV-6and other virus actively replicate.

    Envita employs only the most advanced diagnostic tools to test for a variety of infections like HHV-6, andexamine whether it is a causative factor for other maladies, such as Chronic Fatigue Syndrome. We

    utilize the most effective therapies from around the world to modulate and boost immune function in

    patients suffering with HHV-6 or those who are immunocompromised and at risk of contracting it.

    References:

    Abel-Haq, N.M. and Asmar BI. Human herpesvirus 6 (HHV-6) infection. Indian J. Pediatr. 2004Jan; 71(1): 89-96

    Secchiero, Paola, et al. HHV-6 Infection in Immunocompromised Patients. Infections inMedicine.2005; 22(3).

    Wisconsin Viral Research Group, Ltd. wisconsinlab.com Institute of Human Virology, University of Maryland, Baltimore, Baltimore, MD, (citations for the

    above)

    http://www.medicalnewstoday.com/releases/112548.php this source to site Seror E, DeVillartay P, Leverger G, Lenoir G. SourceService de pdiatriegnrale, hpital Necker-

    Enfants-Malades, AP-HP, 149, rue de Svres, 75743 Paris cedex 15, France

    Dr. David Bell in 2008 on research by Dr. L. Flammand to citation Source Laboratory ofMolecular Virology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland

    20892, USA.

    Journal of the American Society of Hematology citations for above

    http://www.envita.com/conditions-we-treat/lymedisease/http://www.envita.com/conditions-we-treat/lymedisease/http://www.medicalnewstoday.com/releases/112548.phphttp://www.davidsbell.com/LynNewsV5N3.htmhttp://www.davidsbell.com/LynNewsV5N3.htmhttp://www.medicalnewstoday.com/releases/112548.phphttp://www.envita.com/conditions-we-treat/lymedisease/